A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

NCT02055547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: MK-8521 35μg
DRUG: MK-8521 100μg
DRUG: MK-8521 125μg
DRUG: MK-8521 150μg
DRUG: MK-8521 175μg
DRUG: MK-8521 200μg
DRUG: MK-8521 300μg
DRUG: MK-8521 50/72μg
DRUG: MK-8521 72/125μg
DRUG: MK-8521 100/150μg
DRUG: MK-8521 125/150μg
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC